Note: Ingredients listed on restricted chemical lists
EC/CAS
64742-81-0
Name of the chemical
Kerosine (petroleum), hydrodesulfurized
Concentration
N/A
General Information
Revision date
2010-06-18
Product name
PETROSOL 3355
CAS No.
64742-81-0
1.2.1 Relevant identified uses
This product is an aliphatic solvent that can also be used as kerosene (fuel for non- vented space heaters and wick-fed illuminating lamps)
Manufacturer Name
PETRO-CANADA
Icons in SDS
Company Information
company name
PETRO-CANADA
Section 2
SECTION 2: Hazards identification
Physical state Clear liquid. Odour : Hydrocarbon. WHMIS (Canada) Class B-3: Combustible liquid with a flash point between 37.8°C (100°F) and 93.3°C (200°F). Class D-2A: Material causing other toxic effects (Very toxic). Class D-2B: Material causing other toxic effects (Toxic). OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview CAUTION! COMBUSTIBLE LIQUID AND VAPOUR. MAY CAUSE SKIN IRRITATION. Combustible liquid. Moderately irritating to the skin. Keep away from heat, sparks and flame. Avoid breathing vapour or mist. Avoid contact with eyes, skin and clothing. Use only with adequate ventilation. Wash thoroughly after handling.
Principle Routes of Exposure
Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Inhalation Inhalation of this product may cause respiratory tract irritation and Central Nervous System (CNS) Depression, symptoms of which may include; weakness, dizziness, slurred speech, drowsiness, unconsciousness and in cases of severe overexposure; coma and death. Ingestion Ingestion of this product may cause gastro-intestinal irritation. Aspiration of this product may result in severe irritation or burns to the respiratory tract. Skin Moderately irritating to the skin. Eyes May cause eye irritation.
Potential chronic health
effects : No known significant effects or critical hazards. Carcinogenicity : Contains material which may cause cancer, based on animal data. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Medical conditions : Repeated skin exposure can produce local skin destruction or dermatitis. aggravated by over- exposure See toxicological information (Section 11) 3 .